Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Enzo Biochem - 44 Year Stock Price History | ENZ

Historical daily share price chart and data for Enzo Biochem since 1980 adjusted for splits and dividends. The latest closing stock price for Enzo Biochem as of November 29, 2024 is 1.08.
  • The all-time high Enzo Biochem stock closing price was 111.30 on January 21, 2000.
  • The Enzo Biochem 52-week high stock price is 1.50, which is 38.9% above the current share price.
  • The Enzo Biochem 52-week low stock price is 0.93, which is 13.9% below the current share price.
  • The average Enzo Biochem stock price for the last 52 weeks is 1.18.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Enzo Biochem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 1.0732 1.3684 1.3684 0.9488 1.0800 -14.83%
2023 1.5115 1.2589 2.4267 0.9123 1.2681 -2.80%
2022 2.2885 2.8554 3.1656 1.0582 1.3046 -55.45%
2021 2.9676 2.4267 3.7312 2.3811 2.9284 27.38%
2020 2.1841 2.5179 3.5305 1.6604 2.2989 -4.18%
2019 3.0384 2.5544 3.9319 2.3172 2.3993 -5.39%
2018 4.7693 7.5263 7.6267 2.2442 2.5361 -65.89%
2017 8.4497 6.5137 10.7558 5.8386 7.4351 17.44%
2016 5.1079 4.2786 6.8239 3.7039 6.3312 54.22%
2015 3.0454 4.0596 4.5158 2.2168 4.1053 1.35%
2014 4.0840 2.6639 5.5467 2.4540 4.0505 52.05%
2013 2.2549 2.5088 2.8281 1.7698 2.6639 8.15%
2012 2.0322 2.1621 2.7825 1.3319 2.4632 20.54%
2011 3.2497 5.0175 5.2821 1.8154 2.0435 -57.58%
2010 4.4597 5.1726 6.0849 3.0744 4.8168 -1.86%
2009 4.5780 4.6526 6.9881 2.6456 4.9081 10.02%
2008 8.5753 11.8414 13.5291 3.1930 4.4611 -61.62%
2007 13.0691 13.2919 17.0140 9.1684 11.6225 -10.72%
2006 11.6955 11.4491 14.5965 8.4842 13.0182 14.90%
2005 14.0645 17.6070 17.6070 11.3305 11.3305 -36.21%
2004 14.8230 16.3754 18.6561 10.6828 17.7621 8.71%
2003 16.2081 13.3193 25.9361 10.5095 16.3389 27.93%
2002 15.1488 22.3965 23.4639 10.6281 12.7719 -40.43%
2001 20.9627 19.8968 31.9116 12.7263 21.4386 -5.55%
2000 49.2612 40.1404 111.2982 18.6470 22.6975 -45.91%
1999 16.1535 9.4695 42.7677 7.4123 41.9649 346.17%
1998 11.1848 13.3467 14.8246 5.9298 9.4056 -29.53%
1997 14.5703 16.8772 18.8204 11.8596 13.3467 -19.26%
1996 15.8221 18.0175 19.2765 13.0000 16.5305 -5.87%
1995 12.9719 10.3818 21.6667 8.7807 17.5614 72.96%
1994 11.3191 14.5965 17.6800 7.0702 10.1537 -29.91%
1993 9.8601 7.0702 18.1361 5.9298 14.4870 115.32%
1992 4.6435 3.0744 6.8421 2.9649 6.7281 96.66%
1991 1.5038 1.7151 7.1888 0.4561 3.4211 76.05%
1990 2.7572 3.5305 4.1053 1.5965 1.9432 -41.16%
1989 3.3111 2.8554 4.4428 2.3993 3.3025 11.39%
1988 3.6041 3.6491 4.4428 2.2807 2.9649 -13.33%
1987 7.6990 7.9825 11.0568 2.9649 3.4211 -57.14%
1986 11.6152 11.0568 17.1053 7.6449 7.9825 -29.26%
1985 12.9233 13.9123 19.1579 9.4604 11.2849 -17.53%
1984 14.9453 23.3726 23.9474 11.1754 13.6842 -39.69%
1983 22.5439 14.8215 30.5614 14.8215 22.6884 40.77%
1982 9.4326 9.5789 16.1170 5.0175 16.1170 66.98%
1981 8.4781 3.3055 13.7572 3.1535 9.6519 192.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.056B $0.032B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $152.052B 14.72
Vertex Pharmaceuticals (VRTX) United States $120.557B 0.00
Bristol Myers Squibb (BMY) United States $120.109B 50.62
Gilead Sciences (GILD) United States $115.379B 20.90
CSL (CSLLY) Australia $88.978B 0.00
Regeneron Pharmaceuticals (REGN) United States $82.441B 18.76
GSK (GSK) United Kingdom $70.736B 8.18
Argenex SE (ARGX) Netherlands $37.220B 0.00
Alnylam Pharmaceuticals (ALNY) United States $32.641B 0.00
BioNTech SE (BNTX) Germany $28.383B 0.00
Biogen (BIIB) United States $23.407B 10.05
Illumina (ILMN) United States $22.862B 83.32
BeiGene (BGNE) Cayman Islands $20.940B 0.00
Moderna (MRNA) United States $16.570B 0.00
Incyte (INCY) United States $14.370B 0.00
Genmab (GMAB) Denmark $14.228B 20.87
Insmed (INSM) United States $13.446B 0.00
Sarepta Therapeutics (SRPT) United States $12.737B 114.95
BioMarin Pharmaceutical (BMRN) United States $12.584B 29.22
Bio-Techne Corp (TECH) United States $11.974B 46.23
Vaxcyte (PCVX) United States $11.758B 0.00
Exact Sciences (EXAS) United States $11.490B 0.00
Exelixis (EXEL) United States $10.412B 23.67
QIAGEN (QGEN) Netherlands $9.911B 20.39
Revolution Medicines (RVMD) United States $9.731B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.407B 31.97
Roivant Sciences (ROIV) United Kingdom $9.252B 0.00
Intra-Cellular Therapies (ITCI) United States $9.080B 0.00
Repligen (RGEN) United States $8.434B 109.88
Ascendis Pharma (ASND) Denmark $8.252B 0.00
Legend Biotech (LEGN) United States $7.718B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.351B 7.19
Nuvalent (NUVL) United States $6.869B 0.00
Halozyme Therapeutics (HALO) United States $6.132B 13.85
Blueprint Medicines (BPMC) United States $6.123B 0.00
Cytokinetics (CYTK) United States $6.120B 0.00
Viking Therapeutics (VKTX) United States $5.899B 0.00
Krystal Biotech (KRYS) United States $5.678B 94.01
Telix Pharmaceuticals (TLX) $5.520B 0.00
TG Therapeutics (TGTX) United States $5.417B 0.00
Avidity Biosciences (RNA) United States $5.134B 0.00
Arcellx (ACLX) United States $4.762B 0.00
Axsome Therapeutics (AXSM) United States $4.760B 0.00
ADMA Biologics Inc (ADMA) United States $4.754B 50.28
Alkermes (ALKS) Ireland $4.696B 15.77
Biohaven (BHVN) United States $4.653B 0.00
Guardant Health (GH) United States $4.400B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.398B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $4.368B 0.00
Apellis Pharmaceuticals (APLS) United States $4.221B 0.00
Immunovant (IMVT) United States $4.139B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.813B 0.00
Scholar Rock Holding (SRRK) United States $3.735B 0.00
Denali Therapeutics (DNLI) United States $3.598B 0.00
ImmunityBio (IBRX) United States $3.512B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.478B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.250B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.239B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.168B 0.00
Vera Therapeutics (VERA) United States $3.150B 0.00
Zai Lab (ZLAB) China $3.134B 0.00
Edgewise Therapeutics (EWTX) United States $3.125B 0.00
SpringWorks Therapeutics (SWTX) United States $3.086B 0.00
Merus (MRUS) Netherlands $3.070B 0.00
Kymera Therapeutics (KYMR) United States $3.034B 0.00
Amicus Therapeutics (FOLD) United States $2.982B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.955B 0.00
Twist Bioscience (TWST) United States $2.919B 0.00
Vericel (VCEL) United States $2.870B 969.00
Iovance Biotherapeutics (IOVA) United States $2.841B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.716B 20.92
Protagonist Therapeutics (PTGX) United States $2.610B 16.47
Geron (GERN) United States $2.491B 0.00
Janux Therapeutics (JANX) United States $2.373B 0.00
IDEAYA Biosciences (IDYA) United States $2.365B 0.00
CG Oncology (CGON) United States $2.350B 0.00
Longboard Pharmaceuticals (LBPH) United States $2.342B 0.00
Keros Therapeutics (KROS) United States $2.339B 0.00
WAVE Life Sciences (WVE) Singapore $2.303B 0.00
Ligand Pharmaceuticals (LGND) United States $2.295B 57.30
NeoGenomics (NEO) United States $2.276B 0.00
Beam Therapeutics (BEAM) United States $2.266B 0.00
Akero Therapeutics (AKRO) United States $2.241B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.219B 0.00
NovoCure (NVCR) Jersey $2.168B 0.00
Bavarian Nordic (BVNRY) Denmark $2.152B 13.19
Apogee Therapeutics (APGE) United States $2.033B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.005B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.977B 16.43
Belite Bio (BLTE) United States $1.937B 0.00
Structure Therapeutics (GPCR) United States $1.898B 0.00
Fortrea Holdings (FTRE) United States $1.888B 60.14
Disc Medicine (IRON) United States $1.888B 0.00
MannKind (MNKD) United States $1.870B 48.43
Arvinas (ARVN) United States $1.836B 0.00
Galapagos (GLPG) Belgium $1.821B 0.00
Celldex Therapeutics (CLDX) United States $1.820B 0.00
Certara (CERT) United States $1.805B 50.96
Viridian Therapeutics (VRDN) United States $1.707B 0.00
Dynavax Technologies (DVAX) United States $1.691B 98.92
Immunocore Holdings (IMCR) United Kingdom $1.638B 0.00
Neumora Therapeutics (NMRA) United States $1.606B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.594B 0.00
Intellia Therapeutics (NTLA) United States $1.591B 0.00
Nurix Therapeutics (NRIX) United States $1.566B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.526B 0.00
Praxis Precision Medicines (PRAX) United States $1.494B 0.00
Myriad Genetics (MYGN) United States $1.481B 0.00
Travere Therapeutics (TVTX) United States $1.468B 0.00
Spyre Therapeutics (SYRE) United States $1.462B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.427B 0.00
Arcus Biosciences (RCUS) United States $1.413B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.405B 0.00
Novavax (NVAX) United States $1.397B 0.00
MiMedx (MDXG) United States $1.359B 35.58
Mesoblast (MESO) Australia $1.335B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.312B 0.00
ANI Pharmaceuticals (ANIP) United States $1.203B 16.40
Upstream Bio (UPB) United States $1.172B 0.00
Gyre Therapeutics (GYRE) United States $1.170B 0.00
Bicara Therapeutics (BCAX) United States $1.131B 0.00
Septerna (SEPN) United States $1.123B 0.00
Vir Biotechnology (VIR) United States $1.096B 0.00
Cogent Biosciences (COGT) United States $1.050B 0.00
ArriVent BioPharma (AVBP) United States $1.010B 0.00
Immatics (IMTX) Germany $0.993B 0.00
LENZ Therapeutics (LENZ) United States $0.979B 0.00
Liquidia Technologies (LQDA) United States $0.978B 0.00
Nuvation Bio (NUVB) United States $0.976B 0.00
Zymeworks (ZYME) United States $0.970B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.970B 0.00
Replimune (REPL) United States $0.963B 0.00
89BIO (ETNB) United States $0.954B 0.00
Poseida Therapeutics (PSTX) United States $0.907B 0.00
AbCellera Biologics (ABCL) Canada $0.889B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.883B 0.00
Adaptive Biotechnologies (ADPT) United States $0.877B 0.00
Prothena (PRTA) Ireland $0.872B 0.00
Kura Oncology (KURA) United States $0.859B 0.00
Castle Biosciences (CSTL) United States $0.848B 151.40
Immunome (IMNM) United States $0.846B 0.00
Cytek Biosciences (CTKB) United States $0.841B 0.00
Pliant Therapeutics (PLRX) United States $0.840B 0.00
CARGO Therapeutics (CRGX) United States $0.837B 0.00
Rapport Therapeutics (RAPP) United States $0.835B 0.00
Erasca (ERAS) United States $0.809B 0.00
Anavex Life Sciences (AVXL) United States $0.802B 0.00
Tyra Biosciences (TYRA) United States $0.793B 0.00
Avid Bioservices (CDMO) United States $0.783B 0.00
Cullinan Therapeutics (CGEM) United States $0.783B 0.00
Pacira BioSciences (PCRX) United States $0.781B 7.35
AnaptysBio (ANAB) United States $0.760B 0.00
Entrada Therapeutics (TRDA) United States $0.744B 12.51
Tectonic Therapeutic (TECX) United States $0.734B 0.00
Dianthus Therapeutics (DNTH) United States $0.710B 0.00
Oric Pharmaceuticals (ORIC) United States $0.699B 0.00
MBX Biosciences (MBX) United States $0.680B 0.00
BioAge Labs (BIOA) United States $0.674B 0.00
Arbutus Biopharma (ABUS) United States $0.656B 0.00
Oculis Holding AG (OCS) Switzerland $0.650B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
CureVac (CVAC) Germany $0.643B 5.22
Stoke Therapeutics (STOK) United States $0.641B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.636B 0.00
Mineralys Therapeutics (MLYS) United States $0.636B 0.00
Sana Biotechnology (SANA) United States $0.621B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.607B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.604B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.599B 0.00
CorMedix Inc (CRMD) United States $0.598B 0.00
IGM Biosciences (IGMS) United States $0.597B 0.00
ChromaDex (CDXC) United States $0.590B 772.00
GRAIL (GRAL) United States $0.588B 0.00
Astria Therapeutics (ATXS) United States $0.586B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.584B 0.00
Olema Pharmaceuticals (OLMA) United States $0.580B 0.00
Third Harmonic Bio (THRD) United States $0.575B 0.00
Annexon (ANNX) United States $0.575B 0.00
Humacyte (HUMA) United States $0.569B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.559B 0.00
Emergent Biosolutions (EBS) United States $0.548B 0.00
Abivax SA (ABVX) France $0.540B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.534B 0.00
PureTech Health (PRTC) United States $0.532B 0.00
Terns Pharmaceuticals (TERN) United States $0.530B 0.00
MeiraGTx Holdings (MGTX) United States $0.529B 0.00
Allogene Therapeutics (ALLO) United States $0.520B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.501B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.500B 0.00
Pharming Group (PHAR) Netherlands $0.499B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.497B 0.00
REGENXBIO (RGNX) United States $0.491B 0.00
Zenas BioPharma (ZBIO) United States $0.481B 0.00
Cartesian Therapeutics (RNAC) United States $0.479B 0.00
Celcuity (CELC) United States $0.475B 0.00
Sangamo Therapeutics (SGMO) United States $0.472B 0.00
Aura Biosciences (AURA) United States $0.465B 0.00
GH Research (GHRS) Ireland $0.465B 0.00
ACELYRIN, INC (SLRN) United States $0.456B 0.00
Foghorn Therapeutics (FHTX) United States $0.444B 0.00
Alumis (ALMS) United States $0.437B 0.00
Prime Medicine (PRME) United States $0.432B 0.00
Tango Therapeutics (TNGX) United States $0.423B 0.00
Alpha Teknova (TKNO) United States $0.398B 0.00
XOMA Royalty (XOMA) United States $0.394B 0.00
Contineum Therapeutics (CTNM) United States $0.384B 0.00
EnGene Holdings (ENGN) Canada $0.382B 0.00
Revance Therapeutics (RVNC) United States $0.379B 0.00
Neurogene (NGNE) United States $0.378B 0.00
Voyager Therapeutics (VYGR) United States $0.375B 9.66
MaxCyte (MXCT) United States $0.374B 0.00
Codexis (CDXS) United States $0.373B 0.00
Northwest Biotherapeutics (NWBO) United States $0.371B 0.00
Fate Therapeutics (FATE) United States $0.361B 0.00
Kodiak Sciences (KOD) United States $0.351B 0.00
Absci (ABSI) United States $0.350B 0.00
Eton Pharmaceuticals (ETON) United States $0.350B 0.00
Jasper Therapeutics (JSPR) United States $0.342B 0.00
Design Therapeutics (DSGN) United States $0.340B 0.00
Kamada (KMDA) Israel $0.339B 21.04
AC Immune (ACIU) Switzerland $0.336B 0.00
Q32 Bio (QTTB) United States $0.328B 0.00
C4 Therapeutics (CCCC) United States $0.321B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.314B 0.00
ITeos Therapeutics (ITOS) United States $0.312B 0.00
Artiva Biotherapeutics (ARTV) United States $0.310B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.300B 0.00
Urogen Pharma (URGN) United States $0.298B 0.00
ATyr Pharma (ATYR) United States $0.296B 0.00
Prima BioMed (IMMP) Australia $0.295B 0.00
Rezolute (RZLT) United States $0.292B 0.00
UniQure (QURE) Netherlands $0.291B 0.00
Atea Pharmaceuticals (AVIR) United States $0.289B 0.00
Ocugen (OCGN) United States $0.286B 0.00
Tenaya Therapeutics (TNYA) United States $0.283B 0.00
Mersana Therapeutics (MRSN) United States $0.282B 0.00
Nautilus Biotechnology (NAUT) United States $0.281B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.278B 0.00
Abeona Therapeutics (ABEO) United States $0.278B 0.00
TuHURA Biosciences (HURA) United States $0.277B 0.00
Precigen (PGEN) United States $0.273B 0.00
Lifecore Biomedical (LFCR) United States $0.273B 0.00
Biomea Fusion (BMEA) United States $0.262B 0.00
Anika Therapeutics (ANIK) United States $0.260B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.257B 0.00
TScan Therapeutics (TCRX) United States $0.255B 0.00
Alector (ALEC) United States $0.254B 0.00
Kyverna Therapeutics (KYTX) United States $0.249B 0.00
DiaMedica Therapeutics (DMAC) United States $0.242B 0.00
Verastem (VSTM) United States $0.238B 0.00
Applied Therapeutics (APLT) United States $0.236B 0.00
Molecular Partners AG (MOLN) Switzerland $0.235B 0.00
Benitec Biopharma (BNTC) United States $0.234B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.234B 0.00
XBiotech (XBIT) United States $0.232B 0.00
BioStem Technologies (BSEM) $0.231B 20.40
Semper Paratus Acquisition (TVGN) United States $0.229B 0.00
Solid Biosciences (SLDB) United States $0.228B 0.00
Compass Therapeutics (CMPX) United States $0.224B 0.00
Trevi Therapeutics (TRVI) United States $0.221B 0.00
Inhibrx Biosciences (INBX) United States $0.221B 0.00
Sutro Biopharma (STRO) United States $0.219B 0.00
Climb Bio (CLYM) United States $0.217B 0.00
Opthea (OPT) Australia $0.215B 0.00
Checkpoint Therapeutics (CKPT) United States $0.214B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Amarin (AMRN) Ireland $0.208B 0.00
Fulcrum Therapeutics (FULC) United States $0.208B 0.00
2seventy Bio (TSVT) United States $0.206B 0.00
Nkarta (NKTX) United States $0.203B 0.00
Zura Bio (ZURA) United States $0.199B 0.00
Caribou Biosciences (CRBU) United States $0.198B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.198B 0.00
Bright Minds Biosciences (DRUG) United States $0.195B 0.00
Ventyx Biosciences (VTYX) United States $0.190B 0.00
Greenwich LifeSciences (GLSI) United States $0.187B 0.00
Cabaletta Bio (CABA) United States $0.187B 0.00
Editas Medicine (EDIT) United States $0.185B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.184B 0.00
ScPharmaceuticals (SCPH) United States $0.181B 0.00
Instil Bio (TIL) United States $0.176B 0.00
Sagimet Biosciences (SGMT) United States $0.175B 0.00
Inozyme Pharma (INZY) United States $0.174B 0.00
Seres Therapeutics (MCRB) United States $0.167B 0.00
Puma Biotechnology (PBYI) United States $0.166B 7.06
Adherex Technologies (FENC) United States $0.166B 0.00
PepGen (PEPG) United States $0.165B 0.00
Actuate Therapeutics (ACTU) United States $0.159B 0.00
Gossamer Bio (GOSS) United States $0.158B 0.00
Candel Therapeutics (CADL) United States $0.153B 0.00
Black Diamond Therapeutics (BDTX) United States $0.150B 0.00
Seer (SEER) United States $0.146B 0.00
InflaRx (IFRX) Germany $0.145B 0.00
Elutia (ELUT) United States $0.143B 0.00
Cidara Therapeutics (CDTX) United States $0.142B 0.00
Compugen (CGEN) Israel $0.142B 79.50
Coherus BioSciences (CHRS) United States $0.141B 0.00
Repare Therapeutics (RPTX) Canada $0.139B 0.00
Inventiva S.A (IVA) France $0.139B 0.00
Adverum Biotechnologies (ADVM) United States $0.138B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.136B 0.00
Skye Bioscience (SKYE) United States $0.136B 0.00
Cardiff Oncology (CRDF) United States $0.133B 0.00
Innate Pharma S.A (IPHA) France $0.125B 0.00
TELA Bio (TELA) United States $0.124B 0.00
Scilex Holding (SCLX) United States $0.123B 0.00
Renovaro (RENB) United States $0.120B 0.00
Alto Neuroscience (ANRO) United States $0.119B 0.00
Monopar Therapeutics (MNPR) United States $0.119B 0.00
Cellectis S.A (CLLS) France $0.117B 0.00
Rani Therapeutics Holdings (RANI) United States $0.116B 0.00
Leap Therapeutics (LPTX) United States $0.114B 0.00
Inovio Pharmaceuticals (INO) United States $0.113B 0.00
INmune Bio (INMB) United States $0.112B 0.00
Immunic (IMUX) United States $0.112B 0.00
Akoya Biosciences (AKYA) United States $0.109B 0.00
Coya Therapeutics (COYA) United States $0.109B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.106B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
Adagene (ADAG) China $0.103B 0.00
Generation Bio (GBIO) United States $0.102B 0.00
MediciNova (MNOV) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.101B 0.00
Vigil Neuroscience (VIGL) United States $0.101B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.100B 0.00
Nuvectis Pharma (NVCT) United States $0.097B 0.00
CAMP4 Therapeutics (CAMP) United States $0.097B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
Adicet Bio (ACET) United States $0.093B 0.00
Genelux (GNLX) United States $0.093B 0.00
23andMe Holding (ME) United States $0.093B 0.00
Annovis Bio (ANVS) United States $0.093B 0.00
Allakos (ALLK) United States $0.092B 0.00
Aligos Therapeutics (ALGS) United States $0.092B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.091B 0.00
FibroBiologics (FBLG) United States $0.091B 0.00
Quince Therapeutics (QNCX) United States $0.090B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Invivyd (IVVD) United States $0.084B 0.00
Ikena Oncology (IKNA) United States $0.083B 0.00
CytomX Therapeutics (CTMX) United States $0.083B 6.24
Adlai Nortye (ANL) Cayman Islands $0.082B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.082B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
BioAtla (BCAB) United States $0.081B 0.00
Ovid Therapeutics (OVID) United States $0.081B 0.00
Agenus (AGEN) United States $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.080B 0.00
Galena Biopharma (SLS) United States $0.080B 0.00
Chimerix (CMRX) United States $0.079B 0.00
VistaGen Therapeutics (VTGN) United States $0.079B 0.00
Invizyne Technologies (IZTC) $0.079B 0.00
Bluebird Bio (BLUE) United States $0.079B 0.00
ALX Oncology Holdings (ALXO) United States $0.078B 0.00
Cue Biopharma (CUE) United States $0.077B 0.00
I-Mab (IMAB) China $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.076B 0.00
BeyondSpring (BYSI) United States $0.075B 0.00
DBV Technologies S.A (DBVT) France $0.075B 0.00
ZIVO Bioscience (ZIVO) United States $0.073B 0.00
Oncolytics Biotech (ONCY) Canada $0.072B 0.00
Atara Biotherapeutics (ATRA) United States $0.070B 0.00
Passage Bio (PASG) United States $0.070B 0.00
X4 Pharmaceuticals (XFOR) United States $0.067B 0.00
CervoMed (CRVO) United States $0.067B 0.00
Immuneering (IMRX) United States $0.065B 0.00
Exicure (XCUR) United States $0.064B 0.00
BGM Group (BGM) China $0.064B 0.00
Spero Therapeutics (SPRO) United States $0.062B 16.29
Aileron Therapeutics (ALRN) United States $0.062B 0.00
Boundless Bio (BOLD) United States $0.061B 0.00
Fortress Biotech (FBIO) United States $0.059B 0.00
Entera Bio (ENTX) Israel $0.059B 0.00
IO Biotech (IOBT) Denmark $0.059B 0.00
Connect Biopharma Holdings (CNTB) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Aadi Bioscience (AADI) United States $0.058B 0.00
Kronos Bio (KRON) United States $0.057B 0.00
Vor Biopharma (VOR) $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Theratechnologies (THTX) Canada $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Kezar Life Sciences (KZR) United States $0.055B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
OnKure Therapeutics (OKUR) United States $0.052B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Dyadic (DYAI) United States $0.051B 0.00
AN2 Therapeutics (ANTX) United States $0.050B 0.00
Omega Therapeutics (OMGA) United States $0.049B 0.00
Rallybio (RLYB) United States $0.049B 0.00
Oncobiologics (OTLK) United States $0.048B 0.00
Xilio Therapeutics (XLO) United States $0.048B 0.00
CalciMedica (CALC) United States $0.047B 0.00
Affimed (AFMD) Germany $0.046B 0.00
Celularity (CELU) United States $0.045B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.044B 0.00
Rapt Therapeutics (RAPT) United States $0.044B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.041B 0.00
Intensity Therapeutics (INTS) United States $0.041B 0.00
Alpha Cognition (ACOG) Canada $0.040B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.040B 0.00
Elevation Oncology (ELEV) United States $0.038B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.037B 0.00
Lumos Pharma (LUMO) United States $0.037B 0.00
Beyond Air (XAIR) United States $0.037B 0.00
Curis (CRIS) United States $0.037B 0.00
Lexaria Bioscience (LEXX) Canada $0.036B 0.00
BRIACELL THERAP (BCTX) Canada $0.036B 0.00
Opus Genetics (IRD) United States $0.035B 0.00
Clene (CLNN) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
OKYO Pharma (OKYO) $0.035B 0.00
Grace Therapeutics (GRCE) Canada $0.034B 0.00
NextCure (NXTC) United States $0.033B 0.00
Forte Biosciences (FBRX) United States $0.032B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Pluri (PLUR) Israel $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.031B 0.00
RenovoRx (RNXT) United States $0.030B 0.00
Longeveron (LGVN) United States $0.030B 0.00
HOOKIPA Pharma (HOOK) United States $0.030B 0.00
Dare Bioscience (DARE) United States $0.030B 0.00
Medicus Pharma (MDCX) $0.029B 0.00
MiNK Therapeutics (INKT) United States $0.029B 0.00
SAB Biotherapeutics (SABS) United States $0.027B 0.00
Equillium (EQ) United States $0.027B 0.00
Chemomab Therapeutics (CMMB) Israel $0.026B 0.00
Bionano Genomics (BNGO) United States $0.026B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.026B 0.00
Femasys (FEMY) United States $0.026B 0.00
LakeShore Biopharma (LSB) China $0.026B 0.00
Athira Pharma (ATHA) United States $0.025B 0.00
Cadrenal Therapeutics (CVKD) United States $0.025B 0.00
GeoVax Labs (GOVX) United States $0.025B 0.00
Bolt Biotherapeutics (BOLT) United States $0.025B 0.00
Ocean Biomedical (OCEA) United States $0.024B 0.00
Pulmatrix (PULM) United States $0.024B 0.00
Lisata Therapeutics (LSTA) United States $0.023B 0.00
Spruce Biosciences (SPRB) United States $0.023B 0.00
IN8bio (INAB) United States $0.022B 0.00
Abpro Holdings (ABP) United States $0.022B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.021B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.021B 0.00
Cocrystal Pharma (COCP) United States $0.021B 0.00
UNITY Biotechnology (UBX) United States $0.021B 0.00
BioAffinity Technologies (BIAF) United States $0.019B 0.00
Gelteq (GELS) Australia $0.019B 0.00
Cyclo Therapeutics (CYTH) United States $0.018B 0.00
Tenax Therapeutics (TENX) United States $0.018B 0.00
HCW Biologics (HCWB) United States $0.018B 0.00
BioXcel Therapeutics (BTAI) United States $0.017B 0.00
Cognition Therapeutics (CGTX) United States $0.017B 0.00
Cara Therapeutics (CARA) United States $0.017B 0.00
Synlogic (SYBX) United States $0.017B 0.00
Aprea Therapeutics (APRE) United States $0.016B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.015B 0.00
NKGen Biotech (NKGN) United States $0.014B 0.00
Cingulate (CING) United States $0.014B 0.00
Novogen (KZIA) Australia $0.014B 0.00
Sensei Biotherapeutics (SNSE) United States $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.013B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.012B 0.00
Imunon (IMNN) United States $0.012B 0.00
Turnstone Biologics (TSBX) United States $0.012B 0.00
COSCIENS Biopharma (CSCI) Canada $0.012B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.010B 0.00
Senti Biosciences (SNTI) United States $0.010B 0.00
Aytu BioPharma (AYTU) United States $0.010B 0.00
Vaccinex (VCNX) United States $0.010B 0.00
Evaxion Biotech (EVAX) Denmark $0.010B 0.00
Apollomics (APLM) United States $0.010B 0.00
Ensysce Biosciences (ENSC) United States $0.010B 0.00
Vincerx Pharma (VINC) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Quantum Biopharma (QNTM) Canada $0.009B 0.00
Biora Therapeutics (BIOR) United States $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Eyenovia (EYEN) United States $0.009B 0.00
Soligenix (SNGX) United States $0.008B 0.00
Moleculin Biotech (MBRX) United States $0.008B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.008B 0.00
Edesa Biotech (EDSA) Canada $0.008B 0.00
Organovo Holdings (ONVO) United States $0.007B 0.00
Syros Pharmaceuticals (SYRS) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
Biofrontera (BFRI) United States $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.006B 0.00
Adial Pharmaceuticals (ADIL) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Carmell (CTCX) United States $0.006B 0.00
GT Biopharma (GTBP) United States $0.006B 0.00
GRI Bio (GRI) United States $0.006B 0.00
Cyclerion Therapeutics (CYCN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Onconetix (ONCO) United States $0.006B 0.00
Elevai Labs (ELAB) United States $0.005B 0.00
Bionomics (BNOX) Australia $0.005B 0.00
Aptevo Therapeutics (APVO) United States $0.005B 0.00
Alzamend Neuro (ALZN) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
NAYA Biosciences (NAYA) United States $0.005B 0.00
Windtree Therapeutics (WINT) United States $0.005B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.005B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Purple Biotech (PPBT) Israel $0.004B 0.00
Portage Biotech (PRTG) $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Polyrizon (PLRZ) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
AquaBounty Technologies (AQB) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Genetic Technologies (GENE) Australia $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
NuCana (NCNA) United Kingdom $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Aptose Biosciences (APTO) Canada $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Tharimmune (THAR) United States $0.003B 0.00
Avalon GloboCare (ALBT) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
TFF Pharmaceuticals (TFFP) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) Luxembourg $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00